Company / Cash & Equivalents
Atai Beckley N.V. Cash & Equivalents History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$85.3M
FY2025
5-year range
$17.5M / $362.3M
FY2021-FY2025
Trend
+387.3%
vs FY2024
Sector context
#153 of 207
Health Care
What the data says
Cash & Equivalents changed +387% YoY in FY2025, a notable deviation from the 5-year average annual change of +95%.
Based on SEC 10-K filings.
$85M in FY2025 with a 5-year CAGR of -2.6%.
Improved from $45M to $85M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -23.5%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Sector benchmark
#153 of 207 in Health CareTop 74% of 207This company $85.3M Sector average $669.5M
▼
-87.3% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.6%, indicating a declining trend.
- In FY2025, cash & equivalents increased 387.3% year-over-year.
- Ranks #153 out of 207 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $85.3M | +387.3% |
| FY2024 | $17.5M | -61.1% |
| FY2023 | $45.0M | -76.4% |
| FY2022 | $190.6M | -47.4% |
| FY2021 | $362.3M | +272.5% |
| FY2020 | $97.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026